No registrations found.
ID
Source
Brief title
Sponsors and support
Intervention
Outcome measures
Primary outcome
(Recurrent) cardiovascular disease, e.g. MI, SAP, UAP, mortality.
Secondary outcome
N/A
Background summary
In the groups AMI, SAP, UAP and controls, the marker concentrations of several potential new risk markers for cardiovascular diseases will be evaluated at inclusion, after 6 months, and after 12 months.
Study objective
We hypothesize that our newly discovered serum risk markers are positively associated with the presence of cardiovascular diseases.
Study design
N/A
Intervention
Venous blood sample.
P.O. Box 5800
M. Lobbes
Debyelaan 25
Maastricht 6202 AZ
The Netherlands
+31 (0)43 3874910
mlob@rdia.azm.nl
P.O. Box 5800
M. Lobbes
Debyelaan 25
Maastricht 6202 AZ
The Netherlands
+31 (0)43 3874910
mlob@rdia.azm.nl
Inclusion criteria
Groups of AMI, SAP, UAP and controls will be formed (n=120). All participants will donate a venous blood sample at inclusion, and after 6 and 12 months. Marker concentration will be evaluated in these blood samples.
Exclusion criteria
1. Unable to give informed consent;
2. CVD < 6 months;
3. Auto-immune diseases;
4. Malignancies;
5. Renal insufficiency (< 40 ml/min Creat clearance).
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL338 |
| NTR-old | NTR376 |
| Other | : N/A |
| ISRCTN | ISRCTN79274394 |